Report Shows Iicon Has Helped Boost Regional R&D Spend to £1 B
06 Nov 2025 //
PHARMIWEB
Venus Remedies In-Licenses MET-X From Infex For India
27 Feb 2025 //
INDPHARMAPOST
Positive study results for Infex’s RESP-X
06 Apr 2023 //
PHARMATIMES
Medivir partner Infex Therapeutics receives FDA QIDP designation
11 Jan 2023 //
PR NEWSWIRE

Market Place
Sourcing Support